KING OF PRUSSIA, Pa., Aug. 26, 2008 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) announces it has completed a corporate restructure and received a new symbol. Emergent believes its restructure, that included a 1 for 50 reverse split, will enhance its viability in the investment community over the long run, as well as increase shareholder value. A tender offer of $2.00 per share is being made to all shareholders who hold fewer than 10 shares after the reverse split. Such shares should be sent to the address at the end of this press release for redemption and payment.
Emergent is also making great strides in the introduction of all of its current products, Hungarest(tm) Diet Aid http://www.appetitecontrolled.com and Vita-Stim(tm) Life Enhancement http://www.vita-stim.com. It also introduced a new product for Physician only dispensing Neuvitale(tm) Life Support.
Emergent engages in the discovery, development and marketing of products designed to better mankind. Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third party label exemptions. Emergent is focusing current efforts on marketing licensed patent pending natural stem cell propagating agents capable of enhancing each individual's ability to increase their own adult stem cells from their bone marrow. Emergent is also licensed under a patent pending application to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and Professional markets. Research and Development is exploring other areas such as Secretogues that can naturally enhance a person's own Growth Hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, legally and utilizing known body mechanisms without the use of drugs. None of its products diagnose, treat, cure or prevent any disease. Emergent was founded in 2006 and newly headquartered in King of Prussia, PA.
This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company. This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
Emergent Health Corp. 20104 Valley Forge Circle King of Prussia, PA 19406